Work

Updated results of phase 1b study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.8564

Authors: Anne C. Chiang, Charles M. Rudin, Alexander I. Spira, Robert M. Jotte, Shirish M. Gadgeel, Alain C. Mita, Lowell L. Hart, William Larry Gluck, Stephen V. Liu, Ann M. Kapoun, Lu Xu, Dawn Hill, Lei Zhou, Jakob Dupont, David R. Spigel

Institutions: Yale Cancer Center, Memorial Sloan Kettering Cancer Center, Virginia Cancer Specialists, Rocky Mountain Cancer Centers, The Barbara Ann Karmanos Cancer Institute, Cedars-Sinai Medical Center, Georgetown University, OncoMed (United States), Sarah Cannon

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2758090557

Cites:

Cited by: 9

Related to: 10